Hypertriglyceridemia
📧 Sign up to get email alerts when something new happens for Hypertriglyceridemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-05-15FDA Approved: FENOFIBRATE — Supplemental Application (Rhodes Pharmaceuticals L.P.)
The FDA approved a supplemental application for fenofibrate from Rhodes Pharmaceuticals L.P., extending regulatory approval for the generic …
-
FDA approval · 2019-05-15FDA Approved: FENOFIBRATE — Supplemental Application (Cipla USA Inc.,)
FDA approved a supplemental application for fenofibrate from Cipla USA Inc., authorizing an updated generic fenofibrate product.
-
FDA approval · 2019-05-15FDA Approved: FENOFIBRATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental ANDA for fenofibrate from Glenmark Pharmaceuticals Inc., USA, authorizing a generic fenofibrate product.
-
FDA approval · 2019-05-15FDA Approved: FENOFIBRATE — Supplemental Application (Bostal LLC)
FDA approved a supplemental application for fenofibrate from Bostal LLC, indicating approved changes to the product's labeling/status.
-
FDA approval · 2019-05-15FDA Approved: FENOFIBRATE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' supplemental application for fenofibrate, resulting in an approved modification to the product's label…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-05-15FDA Approved: FENOFIBRATE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for fenofibrate from Torrent Pharmaceuticals Limited, updating the product's labeling and approved i…
-
FDA approval · 2019-05-15FDA Approved: FENOFIBRATE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for fenofibrate filed by Ajanta Pharma USA Inc., authorizing continued marketing of the product unde…
-
FDA approval · 2019-05-13FDA Approved: FENOFIBRATE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for fenofibrate from ANI Pharmaceuticals, Inc.
-
FDA approval · 2019-04-03FDA Approved: LOVAZA — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for Lovaza (omega-3-acid ethyl esters) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2019-03-28FDA Approved: FENOFIBRIC ACID — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for fenofibric acid from Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2019-03-01FDA Approved: FENOFIBRATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA approved a supplemental ANDA for fenofibrate from Amneal Pharmaceuticals NY LLC, authorizing changes to the approved generic product…
-
FDA approval · 2019-02-25FDA Approved: OMEGA-3-ACID ETHYL ESTERS — Original Application (XLCare Pharmaceuticals, Inc.)
The FDA approved the original application for Omega-3-acid ethyl esters from XLCare Pharmaceuticals, enabling a generic version to be market…
-
FDA approval · 2019-02-19FDA Approved: GEMFIBROZIL — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for gemfibrozil by NorthStar Rx LLC.
-
FDA approval · 2019-02-11FDA Approved: FENOFIBRATE — Original Application (Chartwell RX, LLC)
FDA approved Chartwell RX, LLC's original application for a generic fenofibrate product used to treat hyperlipidemia, hypertriglyceridemia, …
-
FDA approval · 2019-02-04FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for Fenofibrate (NDA021695), a generic fenofibrate product.
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: Orlistat for the Treatment of Type I Hyperlipoproteinemia [Phase 2]
Phase 2 trial update evaluating orlistat for treating Hyperlipoproteinemia Type I and related hypertriglyceridemia conditions.
-
FDA approval · 2018-12-13FDA Approved: GEMFIBROZIL — Supplemental Application (Cadila Pharmaceuticals Limited)
FDA approved a supplemental application for gemfibrozil filed by Cadila Pharmaceuticals Limited, changing the labeling of this generic lipid…
-
FDA approval · 2018-12-11FDA Approved: GEMFIBROZIL — Supplemental Application (Northstar RxLLC)
FDA approved a supplemental application for gemfibrozil under an existing ANDA held by Northstar RxLLC.
-
FDA approval · 2018-11-07FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved a supplemental application for fenofibrate from Lupin Pharmaceuticals, Inc.
-
FDA approval · 2018-11-07FDA Approved: FENOFIBRIC ACID — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for Fenofibric Acid from Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS trial_result · 2018-10-01Clinical Trial Update: AZD0585 Phase III Long-term Study in Japan [Phase 3]
Phase III long-term study in Japan for AZD0585 in hypertriglyceridemia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-09-25Clinical Trial Update: A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweight Subjects. [Phase 2]
Phase 2 double-blind, randomized trial comparing Epanova to fenofibrate on liver fat in overweight individuals with NAFLD or hypertriglyceri…
-
FDA approval · 2018-09-10FDA Approved: FENOFIBRATE — Original Application (Ajanta Pharma USA Inc.)
The FDA approved Ajanta Pharma USA Inc.'s original ANDA for fenofibrate, a generic lipid-lowering medication.
-
FDA approval · 2018-08-28FDA Approved: FENOFIBRATE — Original Application (Solco Healthcare US, LLC)
FDA approved the original application for fenofibrate (generic) from Solco Healthcare US, LLC, authorizing its use for certain lipid disorde…
-
FDA approval · 2018-08-28FDA Approved: GEMFIBROZIL — Original Application (Zydus Lifesciences Limited)
FDA approved the original ANDA for Gemfibrozil from Zydus Lifesciences Limited, making a generic fibrate available in the United States.